Dan Zang

Butyrate as a promising therapeutic target in cancer: From pathogenesis to clinic (Review)

Jinzhe Sun, Shiqian Chen, Dan Zang et al. · International Journal of Oncology · 2024 · 118 citations · Full text

Medicine, Oncology, Pharmacology +16

Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanisms

Xin Chen, Xianping Shi, Chong Zhao et al. · Oncotarget · 2014 · 81 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects <i>in vitro</i> and <i>in vivo</i>

Hongbiao Huang, Yuning Liao, Ningning Liu et al. · Oncotarget · 2015 · 63 citations · Full text

Medicine, Oncology, Pharmacology +13

Upregulation of miR-572 transcriptionally suppresses SOCS1 and p21 and contributes to human ovarian cancer progression

Xin Zhang, Junling Liu, Dan Zang et al. · Oncotarget · 2015 · 62 citations · Full text

Medicine, Cancer Biology, Oncology +17

A novel nickel complex works as a proteasomal deubiquitinase inhibitor for cancer therapy

Chong Zhao, Xin Chen, Dan Zang et al. · Oncogene · 2016 · 58 citations · Full text

Medicine, Cancer Biology, Oncology +8